RxDoctor Payments Data

Christopher Deans, MD

Adult Reconstructive Orthopaedic Surgery · Indianapolis, INNPI 1407207251

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 81.1% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $19,309, more than ten times the $626 reported in 2019.

$29,635in general payments, 2019–2025

Across 114 payments — averaging $259.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$24K
  • Zimmer Biomet$3K
  • Stryker$706
  • Smith+Nephew$617
  • Medical Device Business Services, Inc.$292
  • Linkbio Corp$191
  • plus $460 from 6 others

What the payments were for

  • Consulting fees$16,11654%
  • Speaking & faculty fees$1,5005%
  • Travel & lodging$6,58122%
  • Food & beverage$5,17317%
  • Education$2661%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$208,453
Medicare patients
308
Services billed
703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib18$207
Pantoprazole Sodium12$128
Meloxicam47$95
Oxycodone Hcl11$40
Tramadol Hcl13$37
Amoxicillin39$25
Clindamycin Hcl11$11

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →